# Naturlose (D-Tagatose) Efficacy Evaluation Trial

> **NCT00955747** · PHASE3 · COMPLETED · sponsor: **Robert Lodder** · enrollment: 494 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Tagatose
- **DRUG:** Sugar Substitute Splenda

## Key facts

- **NCT ID:** NCT00955747
- **Lead sponsor:** Robert Lodder
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2014-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955747, "Naturlose (D-Tagatose) Efficacy Evaluation Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00955747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*